Brief Evaluation of Medication Influences and Beliefs

Dolder, Christian R.; Lacro, Jonathan P.; Warren, Kathleen A.; Golshan, Shahrokh; Perkins, Diana O.; Jeste, Dilip V.

doi:10.1097/01.jcp.0000130554.63254.3a

Cited by 70 publications

(17 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Brief Evaluation of Medication Influences and Beliefs (BEMIB): [52] is an 8-item scale measuring costs and benefits of medication use based on Health Belief Model. The BEMIB was developed to identify non-adherence in patients with schizophrenia and related psychotic disorders.…”

Section: Introductionmentioning

confidence: 99%

Measurement of psychiatric treatment adherence

Sajatovic

Velligan

Weiden

et al. 2010

Journal of Psychosomatic Research

139

116

View full text Add to dashboard Cite

Objective-Nonadherence to medications for mental disorders substantially limits treatment effectiveness and results in higher rates of relapse, hospitalization, and disability. Accurate measurement of medication adherence is important not only in adherence research, but also in clinical trials in which medications are being evaluated, and in clinical practice where failure to detect nonadherence results in premature medication changes, unnecessary polypharmacy, and greater likelihoods of functional deteriorations and hospitalizations. This is a review of psychiatric treatment adherence methods and measures arising from a meeting on "Methodological Challenges in Psychiatric Treatment Adherence Research" held on September 27-28, 2007 in Bethesda, MD and organized by the National Institute of Mental Health (NIMH).Methods-This paper reviews the range of modalities currently available for assessing adherence behavior including pill counts, pharmacy records, technology-assisted monitoring, biological assays, and a range of self-report and interviewer-rated scales. Measures of adherence attitudes are also reviewed.Results-Each of the adherence measures described are imperfect estimates of actual medication ingestion but each provides informative estimates of adherence or the attitudinal factors associated with adherence. Measure selection depends on a range of factors including the patient sample, the context in which the measure is being used, and the clinical outcomes expected from various levels of nonadherence. The use of multiple measures of adherence is encouraged to balance the limitations of individual measures.Conclusion-While adherence assessment has become increasingly sophisticated in recent years there remains a need for refinement and expansion on currently available methods and measures.

show abstract

Section: Introductionmentioning

confidence: 99%

Measurement of psychiatric treatment adherence

Sajatovic

Velligan

Weiden

et al. 2010

Journal of Psychosomatic Research

139

116

View full text Add to dashboard Cite

show abstract

“…A patient's attitude toward the effects of the medications predicts the medication discontinuation and the treatment outcome (12)(13)(14)(15)(16). For an easy evaluation and validation of such attitudes, several scales are developed (17,18), among them the 30-item drug attitude inventory (DAI) is one of the first and most widely used ones; and its 10-item version is as good as the original one in schizophrenia (19). DAI is used in different studies.…”

Section: Introductionmentioning

confidence: 99%

Drug Attitude Inventory In Bipolar I Patients: Psychometric Properties

Shariati

Shabani

Arianakia

et al. 2018

Iran J Psychiatry Behav Sci

View full text Add to dashboard Cite

Background: A negative attitude toward treatment is a major obstacle to treat bipolar disorder. Objectives: The current study aimed at assessing the reliability and validity of Persian version of drug attitude inventory (DAI-10) in patients with bipolar I disorder and finding its relationship with patients' compliance in order to predict the disorder. Methods: To assess test-retest reliability, 30 outpatients with bipolar I disorder were selected. They were asked to answer the questions at the onset of the study and four to ten days later. Then, the relationship between DAI-10 scores of 82 patients in bipolar disorder patients' follow-up (BDPF) study, and medication possession ratio (MPR) were investigated. The patients were divided into poor and good compliance, and cut off point of the tool was assigned. Positive and negative predictive value of DAI score was also calculated.

show abstract

“…Subjects’ beliefs about medications can be assessed utilizing the BEMIB, which is a derived from the health belief model. It has been shown to be a reliable and valid measure to detect nonadherence to antipsychotic medications 12. While only tested in the schizophrenic population, the authors advise testing the scale in a variety of disease states and with other types of medications 12.…”

Section: Methodsmentioning

confidence: 99%

“…It has been shown to be a reliable and valid measure to detect nonadherence to antipsychotic medications 12. While only tested in the schizophrenic population, the authors advise testing the scale in a variety of disease states and with other types of medications 12. The WHOQOL-BREF which measures the domains of physical health, psychological health, social relationships, and environment is a shorter version of the original (WHOQOL) and is more convenient for use in clinical trials 13…”

Section: Methodsmentioning

confidence: 99%

The impact of a pharmacist assisted clinic upon medication adherence and quality of life in mental health patients

Lizer

Jawaid

Marsh

et al. 2013

Mental Health Clinician

View full text Add to dashboard Cite

*Objectives: To determine if a pharmacist assisted psychiatric clinic would improve adherence to medications and quality of life over 6 months. The primary study endpoints were the change from baseline in Medication Adherence Rating Scale (MARS), Brief Evaluation of Medication Influences and Beliefs (BEMIB), World Health Organization Quality of Life -BREF (WHOQOL-BREF) scales as well as hospitalizations and emergency room visits. Secondary endpoints included metabolic and physiologic parameters. Methods: A prospective, single-center study conducted at an outpatient psychiatric clinic. Subjects were required to attend 3 clinic visits (baseline, 3 and 6 months) with the pharmacist. Subject and medication histories were obtained at each visit. Subjects' records within the local health system were reviewed for emergency room visits and hospitalizations. Metabolic parameters were assessed at each visit. Results: Twenty-seven subjects enrolled and twenty subjects completed. Total MARS score at baseline and study end were 7.90 and 8.65, respectively. At baseline, 10 (50%) were nonadherent based on the BEMIB and 9 (45%) were nonadherent at 6 months. Statistically significant improvements were seen in 2 domains of the WHOQOL-BREF. Reductions in both ER visits and hospitalizations were achieved. There were significant improvements in total cholesterol and LDL. Conclusions: Improvements were seen in two domains of the WHOQOL-BREF -physical capacity and psychological well-being over the 6 month period. While improvements were seen in various rating scales, due to small sample sizes, these were insignificant improvements. Reductions in hospitalizations and ER visits were also seen during the study and up to 6 months post study. Statistically significant improvements were also seen in both total cholesterol and LDL. The lack of improvement in many of the study outcomes reflects Se solicitó a las personas que acudiesen a 3 visitas a la clínica con el farmacéutico (inicio, 3 y 6 meses). En cada visita se recogió las historias clínicas y medicamentosas. Se revisaron las fichas de los pacientes en el sistema local de salud para las visitas a urgencias y hospitalizaciones. En cada visita se evaluaron los parámetros metabólicos. Resultados: Se evaluó a 27 individuos y 20 completaron el estudio. Las puntuaciones del MARS al inicio y al final fueron 7,90 y 8,65, respectivamente. En el inicio, 10 (50%) eran incumplidores, basándose en el BEMIB y 9 (45%) fueron incumplidores a los 6 meses. Se encontraron mejoras estadísticamente significativas en 2 dominios del WHOQOL-BREF. Se consiguieron reducciones tanto en visitas a urgencias como hospitalizaciones. Hubo mejoras significativas en colesterol total y LDL. Conclusiones: Se encontraron mejoras en dos dominios del WHOQOL-BREF -capacidad física y bienestar psicológico durante el periodo de 6 meses. Aunque se encontraron mejora en varias escalas, debido a los pequeños tamaños de muestra, no fueron significativas. Se vieron reducciones en Lizer MH, Parnapy Jawaid SA, Marsh W, Mogi...

show abstract

Brief Evaluation of Medication Influences and Beliefs

Abstract: The BEMIB represents a promising scale for identifying patients more likely to be nonadherent to their medications.

Cited by 70 publications

References 25 publications

Measurement of psychiatric treatment adherence

Measurement of psychiatric treatment adherence

Drug Attitude Inventory In Bipolar I Patients: Psychometric Properties

The impact of a pharmacist assisted clinic upon medication adherence and quality of life in mental health patients

Contact Info

Product

Resources

About